Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Bausch Health Companies Inc.

Kirkland’s (($TBHC)) has held its Q4 earnings call. Read on for the main highlights of the call. Kirkland’s latest earnings call painted a cautious...

Kirkland’s Earnings Call: Progress Shadowed by Tariff Risks

Brand House Collective ( ($TBHC) ) has issued an announcement. The Brand House Collective, Inc. reported that Chief Operating Officer James E. Schi...

Brand House Collective Announces COO James Schisler Resignation

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bausch Health Companies (BHC – Research Report), F...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Fennec Pharmaceuticals (FENC) and InfuSystem Holdings (INFU)

Analysts have been eager to weigh in on the Financial sector with new ratings on Blue Owl Capital (OWL – Research Report), Banco BBVA Argentina (BB...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BHC	$4.96	-1.78%	2.07M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BHC	$4.96	-1.8%	2.07M
3
4
5
6

BHC

BHC

Get Bausch Health Companies Inc. Data in Excel

Get Bausch Health Companies Inc. Data in Excel